NEW YORK (GenomeWeb) – Namocell, a developer of microfluidic-based single-cell sorting and capturing platforms, has announced a collaboration with researchers at Massachusetts General Hospital to research circulating tumor cells.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.